You are here

Vidya Sundareshan, MD, MPH, FACP, FIDSA

Chief, Department of Internal Medicine, Division of Infectious Diseases
Professor, Department of Internal Medicine, Division of Infectious Diseases
Program Director, Infectious Diseases Fellowship Program
Medical Advisor to Sangamon County Department of Public Health

Education

Medical School: 
Ambedkar Medical College, Bangalore, India
Residency: 
SIU School of Medicine, Springfield, IL - Internal Medicine
Fellowship: 
University of Kentucky, Lexington, KY - Infectious Diseases

Grants

Principle Investigator, community grant: Telligen, PrEP for HIV in at risk population in Southern Illinois. Grnt Amount: $50,000, January 2019.

Principle Investigator in ongoing industry based trials on Ventilator associated pneumonia, Staph aureus treatment with Tedizolid, closed July 2018.

Principal Investigator in ongoing industry based trials on Ventilator associated pneumonia, Staph aureus treatment with Ceftalazone, closed August 2018.

Principal Investigator in ongoing industry based trials on use of telavancin, phase 4 post marketing study: 2015 - 2017, closed.

Completed research as Primary Investigator on heteroresistance in Staphylococcus aureus: Prevalence. SIU School of Medicine. Funded by Memorial Foundation Grant. $21,000. March 2010 - March 2011.

Stamaril for yellow fever. Co-Investigator with Dr. Janak Koirala (PI), 2017 - current.

A Prospective, Randomlized, Double-Blind, Placebo-Conrolled, Multicenter Study to Evaluate the Safe and Efficacy of BAY 41-6551 as Adjunctive Therapy in Intubated and Mechanically-Ventilated Patients with Gram-Negative Pneumonia: Bayer 13084 - Amikacin study (Co-Investigator), closed 2018.

A phase 4, observational, multicenter, 10-year prospective cohort safety study comparing subjects with HIV-associated abdominal lipohypertrophy exposed to Egrifta (tesamorelin for injection) to a similar group of subjects not exposed to Egrifta: EMD Serono Protocol - EGRIFTA LTOS. (Co-Investigator), closed 2018.

Tabs